|
|
|
Volumn 28, Issue 3, 1996, Pages 1449-1450
|
|
Treatment of steroid resistant rejection following renal transplantation: Benefits and risks of OKT3 therapy
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACICLOVIR;
COTRIMOXAZOLE;
CYCLOSPORIN A;
METHYLPREDNISOLONE;
OKT 3;
PREDNISOLONE;
STEROID;
THYMOCYTE ANTIBODY;
ADULT;
AGED;
BRAIN DISEASE;
CLINICAL ARTICLE;
CONFERENCE PAPER;
CYTOMEGALOVIRUS INFECTION;
FEMALE;
HUMAN;
HUMAN TISSUE;
HYPERPYREXIA;
IMMUNOSUPPRESSIVE TREATMENT;
INTRAVENOUS DRUG ADMINISTRATION;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
MALE;
PNEUMOCYSTOSIS;
POSTOPERATIVE COMPLICATION;
PRIORITY JOURNAL;
RESPIRATORY FAILURE;
TREATMENT OUTCOME;
ANTILYMPHOCYTE SERUM;
CYCLOSPORINE;
DRUG RESISTANCE;
GRAFT REJECTION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INCIDENCE;
KIDNEY TRANSPLANTATION;
MUROMONAB-CD3;
PREDNISOLONE;
RETROSPECTIVE STUDIES;
TREATMENT FAILURE;
TREATMENT OUTCOME;
|
|
EID: 0029930827
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (4)
|
|
References (0)
|
